VHCP Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-140,756
Closed -$7.52M 24
2016
Q1
$7.52M Hold
140,756
6.53% 5
2015
Q4
$15.9M Sell
140,756
-1,037,718
-88% -$114M 9.61% 4
2015
Q3
$139M Hold
1,178,474
35.56% 1
2015
Q2
$91.2M Hold
1,178,474
25.74% 1
2015
Q1
$68.2M Hold
1,178,474
15.7% 2
2014
Q4
$38M Hold
1,178,474
10.46% 3
2014
Q3
$28.8M Sell
1,178,474
-367,525
-24% -$7.47M 12.96% 2
2014
Q2
$27.4M Hold
1,545,999
14.65% 2
2014
Q1
$30.9M Hold
1,545,999
16.08% 2
2013
Q4
$25.9M Sell
1,545,999
-64,857
-4% -$897K 13.96% 2
2013
Q3
$17.1M Hold
1,610,856
9.45% 4
2013
Q2
$9.01M Buy
+1,610,856
New +$9.75M 6.69% 5

Other funds holding ANAC

VHCP Management's ANAC Position: Q2 2016 in Review

VHCP Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 140,756 shares — an estimated $7.52M sold.

VHCP Management first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $139M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • VHCP Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • VHCP Management sold 140,756 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $7.52M.
  • VHCP Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • VHCP Management's ANACOR PHARMACEUTICALS INC COM position peaked at $139M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on VHCP Management's 13F filing for Q2 2016, filed 12 Aug 2016.